Segal Lloyd Mitchell 4/A
4/A · Repare Therapeutics Inc. · Filed Jan 24, 2022
Insider Transaction Report
Form 4/AAmended
Segal Lloyd Mitchell
DirectorPRESIDENT AND CEO
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2022-01-21+300,000→ 300,000 totalExercise: $15.63Exp: 2032-01-20→ Common Shares (300,000 underlying)
Footnotes (2)
- [F1]This Form 4 amendment is being filed to correct the original Form 4 filed on January 20, 2022. The original Form 4 was filed early with an incorrect Transaction Date due to a clerical error.
- [F2]Twenty-five percent (25%) of the shares subject to the option shall vest on January 18, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.